pgy1 program
Health-System

Residency Program Director
  • Lisa Glance Mostafavifar, PharmD, BCPS, BCNSP

    • Specialty Practice Pharmacist Acute Care Surgery & Trauma/Nutrition Support
    • PGY1 Residency Director
    • PharmD – West Virginia University School of Pharmacy
    • PGY1 – West Virginia University Hospitals
    • PGY2 Critical Care – Baptist Hospital of Miami

About the PGY1 Health-System Residency Program

Purpose

Residents completing the PGY1 residency program at The Ohio State University Wexner Medical Center will be competent, autonomous and confident clinical pharmacists who are ready to assume a position as a clinical pharmacist, PGY2 resident, or fellow in the acute or ambulatory care setting. Additionally, the program prepares our graduating clinical pharmacists to conduct outcomes related research and provide teaching in the form of preceptorship, didactic education or education to our patients and healthcare partners.

DSC_8724RESIDENCY SITES

As one of America’s top ranked academic medical centers, the mission of The Ohio State University Wexner Medical Center (OSUWMC) is to improve people’s lives through innovation in research, education, and patient care.

OSUWMC is a 1350 bed multihospital delivery system recognized in 2015 as one of “America’s Best Hospitals” for excellence in ten specialties by US News and World Report based on quality, outcomes, and reputation.

More about the sites

University Hospital (UH)

University Hospital (UH) is our flagship hospital with over 900 beds. UH is a major referral center for patients throughout Ohio and the Midwest, and is one of the busiest kidney and pancreas transplant centers in the world. UH is also an international center for neuromodulation research and neurological care. In addition, UH is a level 1 trauma center in addition to being the American Burn Associated verified adult burn center for the region

The James Cancer Hospital and Solove Research Institute

The James Cancer Hospital and Solove Research Institute is one of the nation’s premier centers for the prevention, detection and treatment of cancer.  OSUWMC features the world’s most advanced cancer and critical care hospital which opened in December of 2014. With the opening of the new hospital, our institution boasts an Emergency Department (ED) with over 100 beds and an area dedicated specifically to the care of cancer patients within the ED. Medical Intensive Care, Surgical Intensive Care, Neuro Intensive Care, and Cancer specific ICU patient care areas also exist within the new cancer and critical care tower.

The Ross Heart Hospital

The Ross Heart Hospital is a leader in cardiology and heart surgery and is the only nationally ranked heart hospital in the area. Each floor of the 172-bed hospital is dedicated to a specific service, which helps us provide specialized care for every patient. The Ross is one of the largest centers for the implantation of LVAD devices in the world in addition to providing heart and lung transplants.

University Hospitals East (UHE)

University Hospitals East (UHE) blends the friendly atmosphere of a community hospital with the advantages of being a part of a major academic medical center. Located on the eastern edge of downtown Columbus, University Hospital East offers renowned Ohio State services in orthopedic care, emergency services, cancer care, addiction services, ear, nose and throat care, heart care, radiology and imaging services, rehabilitation and wound healing. University Hospital East has a 19 bed mixed medical/surgical ICU.

Harding Hospital/Dodd Hall

In addition, the OSUWMC boasts Harding Hospital, which offers comprehensive inpatient and outpatient mental and behavioral health services in addition to Dodd Hall, which is a nationally recognized and accredited rehabilitation program specializing in stroke, brain, and spinal cord rehabilitation.

The Brain and Spine Hospital

The Brain and Spine Hospital will open in Fall 2016 and be a state-of-the-art facility for the advanced management, care and healing of patients with neurological disorders.The hospital will consist of 87 private beds and specialized units for stroke and neurovascular, neurotrauma, epilipsy, spine, chronic pain, neuromodulaton, multiple sclerosis, congnitive and movement disorders, as well as an innovative new model for acute spinal cord injuries.

The Department of Pharmacy

The Department of Pharmacy at The OSUWMC is one of the largest in the country. With over 400 employees, and a practice model that includes both clinical pharmacy generalists and clinical pharmacy specialists, our goal is the provision of outstanding, state of the art care. We advise our staff on the best use of medications, develop safeguards for our patients to prevent medication errors and develop transformative pharmacy practice in health-systems. We are guided in this mission by our strategic plan that focuses on five key priorities: optimizing our pharmacy information system, refining our practice model, enhancing our medication safety program, establishing the pharmacy as a workplace of choice in Central Ohio and refining our academic relationships and department scholarship.

Training future generations of pharmacists is a vital part of our mission. Our pharmacists serve as preceptors for our residency programs while providing experiential training for Doctor of Pharmacy (PharmD) students. Our residency program has a 55-year tradition of excellence with our graduates being well-prepared to work at a high-level in a wide-variety of institutional and ambulatory patient care facilities.

The Department of Pharmacy, in partnership with the OSU College of Pharmacy, strives to develop the skills of our residents and provide a residency program that is recognized nationally for the quality and excellence of its graduates.

DSC_8749KEY ROTATIONS / EXPERIENCES

Rotational experiences for the PGY1 residency in acute care are designed to provide the resident with a broad exposure to pharmacy practice and patient populations. One of the most notable features of the PGY1 residency at the OSUWMC is the wide variety of rotation options and flexibility in scheduling.

Read More

The resident is required to complete 6 weeks of orientation in addition to one administrative rotation. Within the first 2 months of residency, residents will be required to complete a clinical rotation in a non-critical care area (internal medicine, general cardiology, etc.) which will help the resident focus on foundational internal medicine concepts. The remaining 9 months of the residency year are composed of elective rotation choices. If desired, the resident may also choose to complete 1 month of research which typically occurs in the month of December.

Rotation selections will be guided by the Residency Program Director, and will ensure the resident achieves a broad range of experiences and exposure to various patient populations.

Other key experiences during the residency will include the completion of a major research project, the completion of 2 audits (abbreviated research projects), participation in a journal club education series, delivery of 2 formal educational lectures, precepting P2 students, and volunteer work at the Columbus Free Clinic. The resident will also have the opportunity to attend the ASHP Midyear Clinical Meeting in addition to presenting their finalized research project at the Great Lakes Pharmacy Residency Conference.

KEY PRECEPTORS

The PGY1 residency program provides a unique opportunity for exposure to highly trained preceptors in many practice areas. Residents may choose rotations in areas such as internal medicine, transplant, surgery, critical care, cardiology, emergency medicine, hematology/oncology, and ambulatory care. In addition to numerous direct patient care rotation opportunities, there are numerous indirect patient care rotation opportunities which include investigational drugs, pharmacy administration, drug information, medication safety, information technology, patient assistance, and academia.

SELECTED RESIDENT RESEARCH

  • Predictability of discordance between LDL cholesterol, non-HDL cholesterol, and LDL particle number in patients of a lipid clinic – Gaborcik JW, Snider MJ, Hevezi M, Wehr AM, Sharma K.
  • Evaluation of clinical and microbiological outcomes in patients with Candida glabrata candidemia stratified according to echinocandin minimum inhibitory concentrations – Matthews C, Brown J, Hutchinson D, Balada-Llasat, J-M, Johnston J, Theodoropoulos N, Bauer KA.
  • QTc Prolongation in the Treatment of ICU-induced Delirium: an investigation of medication-related risk factors – McCoy A, Eiferman DA, Boyd M, Phillips G, Murphy CV.
  • Correlation of pharmacokinetic/pharmacodynamic predictions with clinical and microbiological outcomes in patients with Pseudomonas aeruginosa pneumonia using minimum inhibitory concentrations determined via Etest – McKinley L, Wenzler E, Gerlach A, Johnston JEW, Bazan JA, Bauer KA.
  • The incidence of hypotension with continuous infusion atracurium compared to cisatracurium in the intensive care unit – VanderWeide L, Abdel-Rasoul M, Gerlach A.

BENEFITS AND ADDITIONAL REQUIREMENTS

Application Deadline: January 1, 2017

We welcome applications from non-U.S. citizens who have a “green card” (permanent resident status) or a current visa valid through the entire duration of the residency program. The Ohio State University pharmacy residency programs are NOT able to sponsor visas for pharmacy residents (PGY1 or PGY2).

Required Supplemental Material: 

  • Along with your application, upload your last 2 rotation evaluations (preferably clinical rotations).
  • Also, upload any research project in progress or completed with a description of the project, primary outcomes, your role, number of patients included, and final results if available.

Start Date: June 19, 2017

Annual Salary – $47,500

Vacation Days – 10 days

Staffing Requirement – 24 weekends per year

Completion of a Major Research Project

TEACHING OPPORTUNITIES

Download PDF